|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.54 CNY | +1.62% |
|
+20.79% | +23.89% |
| Apr. 26 | Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
| Apr. 25 | Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Jafron Biomedical Co.,Ltd. at its Annual General Meeting of 2022 on 21 April 2023, appointed Xie Qingwu as non-independent directors, Xu Yanjun, Wen Zhihao and Guo Guoqing as independent directors and Shen Yingjuan as non-employee supervisors.
| 1st Jan change | Capi. | |
|---|---|---|
| +23.89% | 2.95B | |
| -3.77% | 184B | |
| -1.77% | 107B | |
| -1.43% | 67.52B | |
| +2.06% | 50.06B | |
| +9.43% | 45.67B | |
| +3.40% | 41B | |
| +3.04% | 26.73B | |
| +4.64% | 26.47B | |
| +15.23% | 25.05B |
JAFRON BIOMEDICAL CO.,LTD. 
